Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapy

Cancer vaccines are promising treatments to prevent relapse after chemotherapy in acute myeloid leukemia (AML) patients, particularly for those who cannot tolerate intensive consolidation therapies. Here, we report the development of an AML cell membrane-coated nanoparticle (AMCNP) vaccine platform,...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Daniel T., Zhou, Jiarong, Kroll, Ashley V., Fang, Ronnie H., Yan, Ming, Xiao, Crystal, Chen, Xiufen, Kline, Justin, Zhang, Liangfang, Zhang, Dong-Er
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979812/
https://www.ncbi.nlm.nih.gov/pubmed/34845316
http://dx.doi.org/10.1038/s41375-021-01432-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979812/
https://www.ncbi.nlm.nih.gov/pubmed/34845316
http://dx.doi.org/10.1038/s41375-021-01432-w

Ejemplares similares